Global Regulatory Strategy
Mapping defensible pathways across US, EU, and Health Canada jurisdictions for diverse modalities.
Expert Support for INDs, NDAs/MAAs, BLAs, and Device Applications
Combination Products
Skilled in developing submission strategies that anticipate regulatory expectations and streamline pathways from early development through approval.
Clinical Regulatory Strategy
Strategic oversight for clinical trial design, execution, and data submission to accelerate development.
Specialized expertise in the unique regulatory requirements for biosimilars and complex combination products.
Expert Regulatory Authority Meeting Preparation
Strategic Planning
Dossier Compilation
Pre-Meeting Briefing
Meeting Leadership
Defining clear objectives and optimal meeting types (Type A/B/C/D, Q-Subs, scientific advice).
Meticulous preparation and review of all briefing documents for agency submission.
Comprehensive internal team training and rehearsal for effective agency interaction.
Direct leadership and representation at critical meetings with FDA, EMA, Health Canada, and MHRA.
Advisory for C-Suite Decisions
Quality & Compliance Leadership
Building strong, phase‑appropriate quality management systems and helping teams maintain ongoing regulatory compliance with thoughtful structure and reliable support.
Clinical Regulatory, RA CMC & Operations Oversight
Strategic guidance for clinical, Chemistry, Manufacturing, and Controls (CMC) and efficient submission planning.
Executive-level Regulatory Advising
Integrated legal rigor and multi-region submission experience for critical strategic decisions.
Partner with Pinpoint Regulatory Strategy for clear, defensible pathways to market approval.